DIC Asset AG

  • WKN: A1X3XX
  • ISIN: DE000A1X3XX4
  • Land: Deutschland

Nachricht vom 27.09.2021 | 07:30

DIC Asset AG acquires established office property Bonnanova for special fund

DGAP-News: DIC Asset AG / Key word(s): Real Estate
27.09.2021 / 07:30
The issuer is solely responsible for the content of this announcement.

Press release

DIC Asset AG acquires established office property Bonnanova for special fund

  • Total investment costs (TIC) amount to EUR 95.2 million
  • Fully leased office building in Bonn's federal district with public-sector tenant
  • Long WALT of 9.5 years
  • DIC acquisition volume since start of the year now at around EUR 1 billion

Frankfurt am Main, 27 September 2021. DIC Asset AG ("DIC"), ISIN: DE000A1X3XX4, one of Germany's leading listed property companies, just notarised the acquisition of the Bonnanova office property for its open-ended special fund GEG Public Infrastructure II. The transfer of possession, benefits and burdens is scheduled for the turn of the year.

The property, situated in a prime spot of the federal district in Bonn (Godesberger Allee
83-91), is well established as an office location, and offers a lettable area of around 18,600 sqm with high alternative use potential. The property is let in its entirety to the public sector (via the BImA Institute for Federal Real Estate). The weighted average lease term (WALT) is around 9.5 years at the moment. Completed in 1992, the property is being extensively modernised for the tenant at the moment.

The total investment costs (TIC) approximate EUR 95.2 million. This brings the notarised acquisitions volume for both segments of DIC since the start of the year up to c. EUR 1 billion.

"With the Bonnanova asset, we acquired yet another high-end property for our investment fund GEG Public Infrastructure II, whose distinguishing feature is the long-term secured cash flow of a public tenant. The modernization currently underway also increases the attractiveness and value of the property. Our acquisitions since the start of the year now add up to more than EUR 1 billion, and thereby show that we are right on track to achieve our annual targets," commented Sonja Wärntges, CEO of DIC.

About DIC Asset AG:

DIC Asset AG is Germany's leading listed specialist for commercial real estate with more than 20 years of experience on the real estate market and access to a broad-based network of investors. Our business is based on a regional and inter-regional real estate platform with eight offices on the ground in all major German markets. We manage 234 assets with a combined market value of c. EUR 11.3 billion on site, always close to our properties and their occupiers.

The Commercial Portfolio segment represents the proprietary real estate portfolio of DIC Asset AG. Here, we generate steady cash flows from stable rent revenues on long-term leases while also optimising the value of our portfolio assets through active management, and realising gains from sales.

In the Institutional Business segment, we earn recurrent fees from real estate services we provide to national and international institutional investors by structuring and managing investment vehicles that return attractive dividend yields.

DIC Asset AG has been SDAX-listed since June 2006.

IR/PR Contact DIC Asset AG:
Peer Schlinkmann
Leiter Investor Relations & Corporate Communications
Neue Mainzer Str. 20 * MainTor Primus
D-60311 Frankfurt am Main
T +49 69 9454858-1492

27.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021